Cargando…
A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M
BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442703/ https://www.ncbi.nlm.nih.gov/pubmed/28535754 http://dx.doi.org/10.1186/s12864-017-3800-9 |
_version_ | 1783238448556015616 |
---|---|
author | Zai, Xiaodong Yang, Qiaoling Liu, Kun Li, Ruihua Qian, Mengying Zhao, Taoran Li, Yaohui Yin, Ying Dong, Dayong Fu, Ling Li, Shanhu Xu, Junjie Chen, Wei |
author_facet | Zai, Xiaodong Yang, Qiaoling Liu, Kun Li, Ruihua Qian, Mengying Zhao, Taoran Li, Yaohui Yin, Ying Dong, Dayong Fu, Ling Li, Shanhu Xu, Junjie Chen, Wei |
author_sort | Zai, Xiaodong |
collection | PubMed |
description | BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3800-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5442703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54427032017-05-25 A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M Zai, Xiaodong Yang, Qiaoling Liu, Kun Li, Ruihua Qian, Mengying Zhao, Taoran Li, Yaohui Yin, Ying Dong, Dayong Fu, Ling Li, Shanhu Xu, Junjie Chen, Wei BMC Genomics Research Article BACKGROUND: Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology. RESULTS: In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes. CONCLUSIONS: The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3800-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-23 /pmc/articles/PMC5442703/ /pubmed/28535754 http://dx.doi.org/10.1186/s12864-017-3800-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zai, Xiaodong Yang, Qiaoling Liu, Kun Li, Ruihua Qian, Mengying Zhao, Taoran Li, Yaohui Yin, Ying Dong, Dayong Fu, Ling Li, Shanhu Xu, Junjie Chen, Wei A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title | A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title_full | A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title_fullStr | A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title_full_unstemmed | A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title_short | A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M |
title_sort | comprehensive proteogenomic study of the human brucella vaccine strain 104 m |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442703/ https://www.ncbi.nlm.nih.gov/pubmed/28535754 http://dx.doi.org/10.1186/s12864-017-3800-9 |
work_keys_str_mv | AT zaixiaodong acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT yangqiaoling acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liukun acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liruihua acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT qianmengying acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT zhaotaoran acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liyaohui acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT yinying acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT dongdayong acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT fuling acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT lishanhu acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT xujunjie acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT chenwei acomprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT zaixiaodong comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT yangqiaoling comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liukun comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liruihua comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT qianmengying comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT zhaotaoran comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT liyaohui comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT yinying comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT dongdayong comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT fuling comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT lishanhu comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT xujunjie comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m AT chenwei comprehensiveproteogenomicstudyofthehumanbrucellavaccinestrain104m |